Tenofovir vs. entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma beyond Milan criteria after hepatectomy / 中华医学杂志(英文版)
Chinese Medical Journal
; (24): 301-308, 2021.
Article
in En
| WPRIM
| ID: wpr-921264
Responsible library:
WPRO
ABSTRACT
BACKGROUND@#Hepatectomy for hepatocellular carcinoma (HCC) beyond the Milan criteria is shown to be beneficial. However, a high rate of post-operative HCC recurrence hinders the long-term survival of the patients. This study aimed to investigate and compare the impacts of tenofovir (TDF) and entecavir (ETV) on the recurrence of hepatitis B viral (HBV)-related HCC beyond the Milan criteria.@*METHODS@#Data pertaining to 1532 patients who underwent hepatectomy and received antiviral therapy between January 2014 and January 2019 were collected from five centers. Recurrence-free survival (RFS) analysis was performed using the Kaplan-Meier method. Cox proportional hazards regression analysis was performed to determine prognostic factors for HCC recurrence.@*RESULTS@#The analysis incorporates 595 HBV-related HCC patients. The overall 5-year RFS was 21.3%. Among them, 533 and 62 patients received ETV and TDF treatment, respectively. The 1-, 3-, and 5-year RFS rates were 46.3%, 27.4%, and 19.6%, respectively, in the ETV group compared with 65.1%, 41.8%, and 37.2%, respectively, in the TDF group (P < 0.001). Multivariate analysis showed that TDF treatment (hazard ratio [HR] 0.604, P = 0.005), cirrhosis (HR 1.557, P = 0.004), tumor size (HR 1.037, P = 0.008), microvascular invasion (MVI) (HR 1.403, P = 0.002), portal vein tumor thrombus (PVTT) (HR 1.358, P = 0.012), capsular invasion (HR 1.228, P = 0.040), and creatinine levels (CREA) (HR 0.993, P = 0.031) were statistically significant prognostic factors associated with RFS.@*CONCLUSIONS@#Patients with HCC beyond the Milan criteria exhibited a high rate of HCC recurrence after hepatectomy. Compared to the ETV therapy, TDF administration significantly lowered the risk of HCC recurrence.
Full text:
1
Database:
WPRIM
Main subject:
Antiviral Agents
/
Hepatitis B virus
/
Retrospective Studies
/
Carcinoma, Hepatocellular
/
Hepatitis B, Chronic
/
Tenofovir
/
Guanine
/
Hepatectomy
/
Liver Neoplasms
Type of study:
Observational_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Chinese Medical Journal
Year:
2021
Document type:
Article